All the patients underwent clinical assessment, anthropometric measurement, oral glucose tolerance test (OGTT) and laboratory assays
[FDA.gov] Medical Disclaimer This article is for informational and educational purposes only and does not constitute medical advice
Our team gives proper paperwork, simple explanations, and helpful advice so patients feel ready in both work and personal areas
Long-term safety data are sparse, and tolerability issues, particularly gastrointestinal side effects, often interfere with adherence
Your monthly subscription includes provider consultations, treatment guidance, prescription management when clinically appropriate, progress-tracking tools, and ongoing support from the Healthon Care 360 team
[4] [5] The standard of care remains disease-modifying antirheumatic drugs (DMARDs), including conventional synthetic DMARDs like methotrexate as first-line therapy, with escalation to biological DMARDs or targeted synthetic DMARDs if disease activity remains inadequately controlled, following a treat-to-target approach